Muse Capital

Yesterday our Co-Founder @rachelspringate joined @schwabnetwork ’s Next Gen Investing with Alex Coffey and Jenny Horne to talk about why women’s health and women’s sports are some of the most compelling opportunities in today’s reset venture market. From the massive underfunding of women’s health to the explosive growth of women’s sports, Rachel shared how Muse Capital has been building conviction in these spaces for nearly a decade, long before they were “trends.” At Muse Capital, we believe:     •    You can’t have best-in-class women’s sports without best-in-class women’s health     •    Proprietary data in women’s health is one of the biggest advantages in the AI era Proud to see Rachel spotlight these founders, markets, and stories on @schwabnetwork . Listen to the full segment at the link in our bio! 💫 #MuseCapital #WomenInVC #WomensHealth #WomensSports #VentureCapital

Women deserve tools built for their unique bodies and performance needs, not outdated one-size-fits-all solutions. Today, we’re thrilled to announce The Optima Program, the first scalable health and performance platform designed specifically for elite female athletes and sports executives. Until 1993, U.S. clinical trials weren’t required to include women. Women often account for only 35% of participants in sports science studies, and as little as 3% in studies look specifically at how the body works during exercise. Cortisol imbalances from intense training loads and inadequate recovery have measurable consequences for performance, injury risk, and long-term health. The gap between women’s health innovation and real-world application has never been wider, until now. This gap ends now. Partnering with 10 category-defining companies in women’s health to start, Optima delivers science-backed innovations directly into athletes’ hands: Hormone health & cortisol insights from @myelihealth Fertility planning & egg freezing access from @cofertility Advanced breast imaging technology from @besoundbreast Mental health & maternal wellness support from @mavidahealth Performance tampon technology engineered by women from @trysequel Women-focused supplementation & wellness from @hughandgrace and @sisterly_lab Wellness and immunity support from @beekeepers_naturals Doula and postpartum care from @joinmahmee Women’s longevity for women in mid-life from @midihealth Launching with @redbullitasailgp as part of @sailgp ’s Impact League, Optima is already expanding conversations with global women’s sports leagues and teams. The future of women’s sports health is here. Learn more at at the link in bio! P.s. read the substack on Optima by our Co-Founder @assiagrazioli at the link in bio as well! #OptimaProgram #WomenInSports #SportsInnovation #WomensHealth

Really excited for our Co-Founder @assiagrazioli to be part of this year’s @deepbluesportsent at the 2026 Business of Women’s Sports Summit presented by GEICO in NYC on April 14th. Specifically my panel on Future-Proofing Investments. This year, it’s all about incrementality with a focus on new pockets of growth and areas of expansion in women’s sports to ensure the industry’s upward trajectory. Don’t miss it – get your tickets before they sell out at BOWS2026.splashthat.com!

Consumers are reshaping healthcare, and pure DTC rarely delivers long-term impact. At Muse Capital we believe the next wave of healthcare startups should begin with a clear patient need, build a strong consumer-facing brand, and simultaneously collect outcomes data that proves clinical and economic value. From there, pursuing reimbursement and partnerships with payers and health systems allows these companies to scale and reach more patients. Our portfolio companies @midihealth , @mavidahealth and @joinmahmee are examples of this approach in action. Read our contribution to MedCity News (link in bio)! #HealthTech #DigitalHealth #VentureCapital

Our Co-Founder and General Partner @rachelspringate joined Jared Johnson on the @heathcarerap podcast live at ViVE in Los Angeles. They discussed why women’s health is not “niche”, but core to serving half the population; how Muse Capital has spent nearly a decade backing overlooked, underfunded markets; the journey from early belief to unicorn status with companies like @midihealth ; and the rise of the “shadow healthcare system”, where consumers are taking health into their own hands. We are proud to back founders who are reimagining the future of consumer health and women’s health from the ground up. Listen to Rachel’s episode on Healthcare Rap from ViVE at the link in bio to hear how she thinks about investing early, building category leaders, and reshaping the healthcare experience. #MuseCapital #RachelSpringate #HealthcareRap #ViVE #DigitalHealth WomensHealth FemTech VentureCapital ConsumerHealth

Big congratulations to our founding GPs, @assiagrazioli and @rachelspringate , on being named 2026 Power100 Honorees by @_blueprintcapital . Through its @power100family platform, Blueprint recognizes leaders across the investment management ecosystem who are helping shape the future of capital through leadership, access, and long-term impact. We’re honored to see Muse Capital included alongside such an incredible group of industry leaders. Thank you to Blueprint Capital Advisors and the Power100 team for this meaningful recognition.

60 women. 6 continents. Billions in capital deployed. At Muse Capital, we are proud to celebrate our co-founders, @assiagrazioli and @rachelspringate , for their recognition among the #Global60 by Emmeline Ventures for International Women’s Day. These visionary leaders are reshaping the venture capital landscape - owning firms, writing checks, and empowering the next generation of companies. We see you, Assia and Rachel. Congratulations on this well-deserved recognition. Together, we are committed to building a better tomorrow. #IWD #WomenInVenture #MuseCapital Empowerment

We’re thrilled to share highlights from our co-founder, @rachelspringate , moderating the impactful panel on Precision Medicine Powered by Genomic Data this week at ViVe . Rachel engaged in stimulating discussions with esteemed panelists Dr. Andrew Trister from Verily Life Sciences, Dr. James Lu of Helix, and Susan Tousi from DELFI Diagnostics. Together, they delved into the future of healthcare, covering key topics such as implementation challenges, innovative diagnostics, the role of AI, and the integration of genomic and behavioral data. We’re optimistic about the path forward and grateful to ViVe for curating such enlightening conversations that inspire innovation in the healthcare landscape. At Muse Capital, our mission is to invest in untapped companies, empowering founders across various sectors. This event aligns perfectly with our commitment to driving change in technology, sustainability, and health. Let’s continue to shape a brighter future together! #ViVe2026 #PrecisionMedicine #Genomics #HealthcareInnovation #MuseCapital

We are proud to announce that our portfolio company, @besoundbreast , has officially opened its first location in Los Angeles! Led by founder and CEO @baileyreng , BeSound is setting a new standard in breast cancer screening for women with dense breast tissue through advanced ultrasound technology. Their commitment to providing timely, accurate results directly addresses a critical gap in women’s healthcare, particularly for those historically underserved. In the U.S., over 40% of women aged 40 to 74 have dense breast tissue, and up to 50% of cancers may be missed in those with extremely dense breasts. BeSound’s innovative approach is particularly vital, as studies show that mammography alone misses about one in eight breast cancers. BeSound successfully raised $6.8 million in seed funding by reframing the pitch around system-level inefficiencies—missed cancers, unnecessary procedures, and capacity constraints. We are proud to have co-led this funding round alongside esteemed investors such as @kindredventures , @overwaterventures , @_luxcapital , Tom Hale, and Forum Ventures. We extend our gratitude to @stengel.geri for her support in this important endeavor and appreciate @forbes for highlighting BeSound’s groundbreaking work. This launch aligns seamlessly with our investment thesis, which focuses on innovations in preventive health and personalized wellness to address urgent, unmet healthcare needs. We look forward to supporting BeSound as they transform the landscape of women’s health. Read the full article here at the link in our bio!

We are proud to announce that our co-founding Partner, @rachelspringate , will be participating in the Precision Medicine, powered by Genomic Data panel at ViVe on February 24. Rachel will join esteemed experts such as Dr. Andrew Trister of Verily Life Sciences, Dr. James Lu of Helix, and Susan Tousi of DELFI Diagnostics at the West Coast Stage from 1:20 PM to 1:50 PM. At Muse Capital, we are committed to investing in untapped and underestimated companies across various sectors. With a diverse portfolio of over 50 investments—many led by female and underrepresented founders. We are dedicated to shaping a better tomorrow by empowering innovative solutions in technology, sustainability, health, and more. Mark your calendars! Don’t forget to grab your tickets—use our discount code for savings. Let’s drive innovation in healthcare together! #ViVe2026 #PrecisionMedicine #GenomicData #MuseCapital #ViVEvent

Five years ago, @assiagrazioli and @rachelspringate did a deep dive into menopause. Women make up half the population — and every woman will eventually go through this life stage — so we asked a simple question: why was there no real healthcare infrastructure built for it? The need was massive. The care was fragmented. The outcomes were poor. So we built a thesis around the white space, mapped the ecosystem, and spoke to countless companies. None quite had it. What we kept coming back to was the same conclusion: the market needed a virtual, clinician-led care model purpose-built for menopause. Rachel shared this thesis widely. And in 2020, during her first year as a Kauffman Fellow, her incredible classmate @witneymck said: “I know someone building exactly this.” That someone was @joannastrober . From our very first meeting, it was obvious — Joanna is one of the rare ones. Vision, rigor, empathy, and the ability to build at scale. We were proud to write one of the earliest checks into @midihealth — even after being told by more than one older male LP that “menopause is niche.” Now, Midi surpassed a $1B valuation. But what matters more are the outcomes: 28% increase in breast cancer screening adherence 11% increase in colorectal cancer screening adherence Up to 13% reduction in total cost of care Meaningful reductions in A1c and LDL across patients This is what happens when you build healthcare around women instead of forcing women into systems that weren’t designed for them. With over 45 million women covered nationwide, Midi isn’t just building a company — they’re reshaping the standard of care. Proud to be on this journey with Joanna and the entire Midi team. Women’s health isn’t a trend. It’s one of the most important, overdue evolutions in healthcare. And this is only the beginning. Read the full article at the link in bio!

We are thrilled to announce that @snoutpass has raised $110 million in Series A funding. As a vet-based tech solution, Snout addresses the growing gap between pet parents and veterinarians. With veterinary prices rising at twice the inflation rate, Snout offers a preventive care model that enhances financial accessibility for pet owners. Key features of Snout’s offering include: • No credit checks • No interest payments • Predictable monthly plans for pet owners • Upfront payments to veterinarians Snout works exclusively through veterinarians. If you’re a pet parent, you can find a Snout clinic near you or ask your vet to join them! We invested in Snout at the pre-seed stage, and have watched @emily.y.d single-handedly build an exceptional team capable of scaling this vision. Their mission aligns with Muse Capital’s focus on tech-driven solutions that transform everyday life—from parenting and caregiving to financial wellness.